The injection of botulinum toxin type A is a widespread procedure. In 2016, more than 4.9 millions of procedures with botulinum toxin injectable have been performed, recording a 7% increase on an annual basis. The first description of the cosmetic use of this protein was described by Carruthers in 1992, for the treatment of glabellar frown lines.
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Digital photography opened a new era for the measurement of wrinkles. Heckman & Schön-Hupka defined objective and standard parameters to measure the effects of botulinum toxin type A studying brows mobility and brow-to-brow distance. 8 However, only the introduction of three-dimensional photography and digital analysis of the image fully standardized the measurement, making the evaluation of the effects truly objective.
Digital analysis of the cutaneous surface was effective in measuring wrinkles severity and their improvements after botulinum toxin type A on glabellar lines (GL) and crow's feet lines (CFL). 9, 10 Although literature is plenty of evidences of the role of botulinum toxin type A in improving skin wrinkles, 7, 8, 11, 12, 12, 13 its action on skin texture is not clear. The aim of this study was to investigate skin texture employing a digital analysis of the cutaneous surface.
This study represents a post hoc analysis of a previous study where this method was suggested. 10 The aim of this post hoc analysis is the evaluation of the skin texture (evaluation of the depressions of the skin surface) after treatment of GL and CFL with onabotulinumtoxin A. Areas corresponding to GL and CFL have been evaluated by Antera © respectively (3D images acquired by Antera © and analysed by Antera © software).
The system offers 3D-colored (based on degree of the wrinkles) images and graphics that reproduce the percentage of change from the baseline, without any subjective evaluation done by patient and/ or investigator.
| MATERIAL S AND ME THODS
In this post hoc analysis, we evaluated 20 lateral periorbital regions.
We adopted the following exclusion criteria: age <18 years, previous treatment of CFL with absorbable fillers and/or laser treatment in the last 6 months, previous blepharoplasty and/or face-lift in the last 1 year, pregnancy, nursing and immunological disorders.
All patients were affected by moderate-to-severe bilaterally symmetrical CFL at maximum smile. We used the Facial Wrinkle
Scale to determine the baseline CFL (0 = none, 1 = mild, 2 = moderate, and 3 = severe). (Table 1) .
| ME A SUREMENTS
All measurements were performed with a digital 3D camera Pre-operative STR is arbitrarily set to 100%. The measured STR at 4 weeks and 4 months expresses the percentage change from the pre-operative value (Figures 1-9 ). 
| LI M ITATI O N S
One intrinsic limitation of this study is the small measured area. This area has typically a regular surface without excessive concavity or convexity that could affect the measure. This surface allows a replicable and standard measure. However, the effectiveness of this method in other areas has not be investigated.
| RE SULTS
The median age was 54 years (ranging from 35 to 76 years). STR improved in all cases treated with botulinum toxin type A. STR Test T for paired samples was applied to study the statistical significance of this variation. The improvements of STR at 4 weeks and 4 months was both statistically significant (respectively P < .0001
and P = .001), while the difference between STR at 4 weeks and 4 months was not significant (P = .086).
| D ISCUSS I ON
A multitude of studies demonstrated the effectiveness of botulinum toxin type A for lines and wrinkles of the glabellar and frontal region. 16 The evidences of effectiveness and safety of botulinum toxin type A for CFL, increased the indication for the treatment of this area. 17 However, the effects of the toxin on those fine wrinkles that determine skin texture have never been studied with an objective method. Indeed, this analysis requires a proper measurement method, able to detect and quantify the skin texture.
Few methods are able to objectively measure the effects of this toxin on wrinkles and lines. The 3D digital analysis has recently been introduced for this purpose, probing to be easy, precise, and reproducible. 9, 10 Therefore, the Antera 3D ® Software allows the operator to select the investigated area, which is automatically recognized during the subsequent acquisitions. An algorithm is then used to analyze skin surface and measure parameter changes from baseline.
In this study, we administered 12 units of botulinum toxin type A in the peri-orbital region, following guidelines recommendations, In this study has been demonstrated using an objective and digital technique, the effects of botulinum toxin type A, which is able to improve the cutaneous texture of the peri-orbital region. Antera ® could provide for an objective, replicable, easy, and a standard method to monitor the effects of the treatment even in case of fine wrinkles.
| CON CLUS ION
The Antera ® device and software are a valuable, objective, easy, and a reproducible method to assess the effects of the toxin. Clinical scores or self-assessment are not necessary.
The injections of botulinum toxin type A have the potential to effectively improve cutaneous texture at 4 weeks (−17.08%) and 4 months (−12.14%). Despite the small sample of this study and the limited measured area, this method was able to evaluate objectively skin texture and roughness. We believe that this method could be a valuable tool to show the objective improvements to patients, involving follow-up during the treatment period.
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